Table of Contents

• Free Topics
  • About
  • Adrenal Neuroendocrine Tumors
  • Anus
  • Calculator - Adrenal Cortical Carcinoma(Clinical) - TNM Calc
  • Calculator - Adrenal Cortical Carcinoma(Pathological) - TNM Calc
  • Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck
  • Colon and Rectum
  • Conjunctival Carcinoma
  • Esophagus and Esophagogastric Junction: Adenocarcinoma
  • Esophagus and Esophagogastric Junction: Other Histologies
  • Esophagus and Esophagogastric Junction: Squamous Cell Carcinoma
  • Exocrine Pancreas
  • Introduction and Overview
  • Kidney
  • Leukemia: Acute Myeloid Leukemia
  • Lip and Oral Cavity
  • Liver
  • Lung
  • Mucosal Melanoma of the Head and Neck
  • Nasopharynx
  • Neuroendocrine Tumors of the Pancreas
  • Perihilar Bile Ducts
  • Stomach
  • Vulva
• Part I: General Information on Cancer Staging and End-Results Reporting
  • 1. Principles of Cancer Staging
    • 1. Principles of Cancer Staging
    • Additional Staging Descriptors and Guidelines
    • AJCC Prognostic Stage Groups
    • AJCC TNM Staging System: Classifications, Categories and Rules for Staging
    • General Staging Rules
    • Introduction and Overview
    • Stage Classifications
  • 2. Organization of the AJCC Cancer Staging Manual
    • 2. Organization of the AJCC Cancer Staging Manual
    • Cancer Staging Data Form
    • Developing the 8th Edition Project Plan
    • New for This Edition
    • Organization of AJCC Cancer Staging Content
    • Vision for the AJCC Cancer Staging Manual, 8th Edition
  • 3. Cancer Survival Analysis
    • 3. Cancer Survival Analysis
    • Basic Concepts
    • Bibliography
    • Cause-Adjusted Survival
    • Comparison of Survival between Patient Groups
    • Competing Risks/Cumulative Incidence
    • Introduction
    • Patient-, Disease-, and Treatment-Specific Survival
    • Relative Survival
    • Stand ard Error of a Survival Estimate
    • Summary
    • The Kaplan-Meier Method
    • The Life Table Method
  • 4. Risk Models for Individualized Prognosis in the Practice of Precision Oncology
    • 4. Risk Models for Individualized Prognosis in the Practice of Precision Oncology
    • Acknowledgments
    • Background
    • Bibliography
    • Considerations for Use of Prognostication Models
    • Endorsement of Prognostication Models Meeting AJCC Criteria
    • Establishing Endorsement Criteria for Prognostication Models
    • Search Strategy for Prognostication Tools
    • The Evaluation Process
• Part II: Head and Neck
  • 5. Staging Head and Neck Cancers
    • 10. HPV-Mediated (p16+) Oropharyngeal Cancer
    • 11-A. Oropharynx (p16-)
    • 11-B. Hypopharynx
    • 12. Nasal Cavity and Ethmoid Sinus
    • 13-A. Larynx: Supraglottis
    • 13-B. Larynx: Glottis
    • 13-C. Larynx: Subglottis
    • 13-D. Larynx: Not Otherwise Specified
    • 14. Mucosal Melanoma of the Head and Neck
    • 15. Cutaneous Carcinoma of the Head and Neck
    • 5. Staging Head and Neck Cancers
    • 6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck
    • 7-A. Lip and Oral Cavity
    • 7-B. Oral Cavity
    • 8. Major Salivary Gland s
    • 9. Nasopharynx
    • Bibliography
    • Collection of Key Patient and Tumor Factors
    • Distant Metastases
    • Introduction and Overview of Key Concepts
    • Key Changes to Head and Neck Cancer Staging
    • Principles of Staging
    • Regional Lymph Nodes
    • Survival Data
• Part III: Upper Gastrointestinal Tract
  • 16-A. Esophagus and Esophagogastric Junction: Squamous Cell Carcinoma
  • 16-B. Esophagus and Esophagogastric Junction: Adenocarcinoma
  • 16-C. Esophagus and Esophagogastric Junction: Other Histologies
  • 17. Stomach
  • 18-A. Small Intestine: Adenocarcinoma
  • 18-B. Small Intestine: Other Histologies
• Part IV: Lower Gastrointestinal Tract
  • 19. Appendix: Carcinoma
  • 20. Colon and Rectum
  • 21. Anus
• Part V: Hepatobiliary System
  • 22. Liver
  • 23. Intrahepatic Bile Ducts
  • 24. Gallbladder
  • 25. Perihilar Bile Ducts
  • 26. Distal Bile Duct
  • 27. Ampulla of Vater
  • 28. Exocrine Pancreas
• Part VI: Neuroendocrine Tumors
  • 29. Neuroendocrine Tumors of the Stomach
  • 30. Neuroendocrine Tumors of the Duodenum and Ampulla of Vater
  • 31. Neuroendocrine Tumors of the Jejunum and Ileum
  • 32. Neuroendocrine Tumors of the Appendix
  • 33. Neuroendocrine Tumors of the Colon and Rectum
  • 34. Neuroendocrine Tumors of the Pancreas
• Part VII: Thorax
  • 35. Thymus
  • 36. Lung
  • 37. Malignant Pleural Mesothelioma
• Part VIII: Bone
  • 38-A. Bone: Appendicular Skeleton, Trunk, Skull and Facial Bones
  • 38-B. Bone: Spine
  • 38-C. Bone: Pelvis
• Part IX: Soft Tissue Sarcoma
  • 39. Introduction to Soft Tissue Sarcoma
  • 40. Soft Tissue Sarcoma of the Head and Neck
  • 41. Soft Tissue Sarcoma of the Trunk and Extremities
  • 42. Soft Tissue Sarcoma of the Abdomen and Thoracic Visceral Organs
  • 43-A. Gastrointestinal Stromal Tumor: Gastric and Omental
  • 43-B. Gastrointestinal Stromal Tumor: Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal
  • 44. Soft Tissue Sarcoma of the Retroperitoneum
  • 45. Soft Tissue Sarcoma Unusual Histologies and Sites
• Part X: Skin
  • 46. Merkel Cell Carcinoma
  • 47. Melanoma of the Skin
• Part XI: Breast
  • 48-A. Breast
  • 48-A. Breast: Ductal Carcinoma in situ
• Part XII: Female Reproductive Organs
  • 49. Introduction to Female Reproductive Organs
    • 49. Introduction to Female Reproductive Organs
    • 50. Vulva
    • 51. Vagina
    • 52. Cervix Uteri
    • 53. Corpus Uteri: Carcinoma and Carcinosarcoma
    • 54. Corpus Uteri: Adenosarcoma
    • 54. Corpus Uteri: Leiomyosarcoma and Endometrial Stromal Sarcoma
    • 55. Ovary, Fallopian Tube, and Primary Peritoneal Carcinoma
    • 56. Gestational Trophoblastic Neoplasms
    • Introduction
• Part XIII: Male Genital Organs
  • 57. Penis
• Part XIV: Urinary Tract
  • 58. Kidney
  • 59. Renal Pelvis and Ureter: Squamous Cell Carcinoma and Adenocarcinoma
  • 59. Renal Pelvis and Ureter: Urothelial Carcinomas
  • 60. Urinary Bladder: Squamous Cell Carcinoma and Adenocarcinoma
  • 60. Urinary Bladder: Urothelial Carcinomas
  • 61. Male Penile and Female Urethra: Squamous Cell Carcinoma and Adenocarcinoma
  • 61. Male Penile and Female Urethra: Urothelial Carcinomas
  • 61. Prostatic Urethra: Squamous Cell Carcinoma and Adenocarcinoma
  • 61. Prostatic Urethra: Urothelial Carcinomas
• Part XV: Ophthalmic Sites
  • 62. Eyelid Carcinoma
  • 63. Conjunctival Carcinoma
  • 64. Conjunctival Melanoma
  • 65. Uvea: Choroidal and Ciliary Body Melanomas
  • 65. Uvea: Iris Melanomas
  • 66. Retinoblastoma
  • 67. Lacrimal Gland Carcinoma
  • 68. Orbital Sarcoma
  • 69. Ocular Adnexal Lymphoma
• Part XVI: Central Nervous System
  • 70. Brain and Spinal Cord
• Part XVII: Endocrine System
  • 71. Thyroid: Anaplastic
  • 71. Thyroid: Differentiated
  • 72. Thyroid: Medullary
  • 73. Parathyroid
  • 74. Adrenal Cortical Carcinoma
  • 75. Adrenal Neuroendocrine Tumors
• Part XVIII: Hematologic Malignancies
  • 76. Introduction to Hematologic Malignancies
    • 77. Hodgkin Lymphoma
    • 77. Non-Hodgkin Lymphoma: Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma
    • 77. Non-Hodgkin Lymphoma: Diffuse Large B-Cell Lymphoma
    • 77. Non-Hodgkin Lymphoma: Follicular Lymphoma
    • 77. Non-Hodgkin Lymphoma: Mantle Cell Lymphoma
    • 77. Non-Hodgkin Lymphoma: Marginal Zone Lymphoma
    • 77. Non-Hodgkin Lymphoma: Not Otherwise Specified
    • 77. Non-Hodgkin Lymphoma: Peripheral T-Cell Lymphoma
    • 78. Pediatric Hodgkin Lymphomas
    • 78. Pediatric Non-Hodgkin Lymphomas
    • 79. Primary Cutaneous Lymphomas: Mycosis Fungoides and Sezary Syndrome
    • 80. Other Plasma Cell Disorders
    • 80. Plasma Cell Myeloma
    • 81. Leukemia: Acute Lymphoblastic Leukemia in Children
    • 81. Leukemia: Acute Lymphocytic Leukemia in Adults
    • 81. Leukemia: Acute Myeloid Leukemia
    • 81. Leukemia: Chronic Myeloid
    • 81. Leukemia: Unspecified or Other Type
    • Bibliography
    • Introduction
    • Pathology